Pharma Lab
Research Peptide Supplier
Pharma Lab
Research Peptide Supplier
Sixty-five research peptides across ten scientific categories, each produced to the same verified standard and supplied with batch-specific analytical documentation.
Well-designed experiments begin with a guiding question, and identifying the right peptide to study is often the first meaningful challenge a researcher must address. The peptide supply landscape is broad, the terminology can be dense, and distinguishing between serious suppliers and unreliable sources takes longer than it should. This page is designed to make that process easier.
Pharma Lab provides sixty-five research peptides covering virtually every major area of peptide science. Rather than presenting a flat list of product names, the entire catalogue has been organised into ten research categories that reflect how scientists think about and use these compounds in practice. Whether your work is focused on growth hormone regulation, regenerative medicine and tissue repair, longevity biology, metabolic pathways, immune function, reproductive endocrinology, cognitive neuroscience, muscle physiology, dermatological research or emerging specialised fields, the relevant peptides and their scientific context are outlined here.
All peptides on this page are produced to the same high specifications, validated using HPLC and mass spectrometry analysis, and supplied with batch-specific Certificates of Analysis. The science differs from one category to the next. The quality does not.
Growth hormone sits at the centre of one of the most fundamental processes in human biology. It influences how the body builds muscle, metabolises fat, repairs tissue and maintains metabolic balance across each stage of life. The research questions surrounding growth hormone are as varied as its effects, and Pharma Lab provides eleven peptides that enable scientists to study growth hormone regulation from multiple approaches, each with its own mechanism and research profile.
To begin, researchers should understand the distinction between growth hormone-releasing hormone analogues and growth hormone secretagogues within this category. GHRH analogues work by mimicking the natural hormone that signals the pituitary gland to produce and release growth hormone.
CJC-1295 DAC is the long-acting formulation of this peptide class, modified with a Drug Affinity Complex designed to extend its half-life and achieve sustained growth hormone elevation over longer periods. CJC-1295 No-DAC, also referred to as Modified GRF 1-29, takes the opposite approach. Without the DAC modification, it produces a growth hormone release that is more pulsatile — closer to the natural rhythm of the body — and sharper in its profile. Sermorelin operates along the same GHRH pathway but with a slightly different peptide structure, making it one of the most widely studied compounds in this group. Tesamorelin completes the GHRH analogue range and has attracted particular interest in studies regarding visceral fat and metabolic health due to its relevance to research on fat redistribution.
Growth hormone secretagogues reach the same endpoint but through a different pathway. Rather than mimicking the natural releasing hormone, they stimulate growth hormone release by activating the ghrelin receptor. GHRP-2 and GHRP-6 are the two foundational molecules in this class. Both can induce a strong growth hormone secretory response, but each has a slightly different profile. GHRP-6 is the more established secretagogue with a notable appetite-stimulating effect, while GHRP-2 promotes a growth hormone release that is somewhat cleaner, producing less interference with hunger signalling. Hexarelin is one of the most potent secretagogues available, driving growth hormone secretion strongly and carrying an additional layer of research interest for its cardioprotective properties. Ipamorelin stands out within this class for a distinctive reason. It has the unique property of triggering growth hormone release without significantly affecting cortisol and prolactin levels, which can be particularly useful for researchers who want to minimise hormonal interference in their experimental models.
MK-677, sometimes referred to as Ibutamoren, holds a distinctive position within this class. It is not technically a peptide but rather a non-peptide ghrelin receptor agonist that achieves growth hormone secretagogue activity through oral delivery. Its long-acting and orally bioavailable characteristics make it a unique research tool for studies that require sustained growth hormone secretion over an extended period without the need for injectable formats.
At the other end of this spectrum sit HGH 191AA and HGH Fragment 176-191. HGH 191AA is the full synthetic reproduction of the 191-amino acid human growth hormone molecule. It does not stimulate the pituitary to produce growth hormone — it is growth hormone in synthetic form. Researchers use it to examine growth hormone action downstream of the pituitary directly. HGH Fragment 176-191 is far more specific. This C-terminal fragment retains the ability to promote the fat-breakdown actions of full-length growth hormone while losing the growth-promoting effects. That specificity makes it a particularly valuable tool for metabolic and body composition research.
Metabolism is one of the most complex areas in biochemistry. Researchers studying energy expenditure, fat storage and body composition need tools that act on particular pathways rather than producing broad, non-specific effects. Pharma Lab offers seven peptides and research compounds with complementary mechanisms of action that address metabolic regulation from different angles.
5-Amino-1MQ is quickly becoming one of the most actively discussed compounds in metabolic research. It works by inhibiting nicotinamide N-methyltransferase, an enzyme involved in the regulation of cellular energy and fat metabolism. Its mechanism of action is clearly defined: NNMT inhibition results in the modification of energy metabolism at a cellular level, promoting its study across different contexts related to metabolic reprogramming and adipose tissue biology.
AOD-9604 has a structural connection to the growth hormone class but belongs here due to its metabolic specificity. As a fragment of human growth hormone corresponding to amino acids 176-191, AOD-9604 acts as an agonist for lipolysis — the breakdown of stored fat — and an antagonist for lipogenesis — the deposition of new fat. Critically, it achieves this without the generalised growth-promoting effects of full-length growth hormone, making it a cleaner probe for metabolic-specific investigations.
For researchers investigating metabolic mechanisms at the cellular level, AICAR and the AMPK pathway offer access to one of the major metabolic switches in the body. AICAR activates AMP-activated protein kinase, a master regulator of cellular energy balance. It is often described as an exercise mimetic due to its ability to induce some of the same metabolic adaptations caused by physical exercise. The AMPK pathway modulator represents a second avenue of study for understanding how cells sense and respond to their energy status.
MOTS-C operates on an entirely different set of principles. It is a mitochondrial-derived peptide encoded within the mitochondrial genome rather than the nuclear genome, placing it within an emerging area of metabolic research that continues to expand. MOTS-C has been associated with metabolic homeostasis, insulin sensitivity and exercise physiology, making it a compelling target for researchers interested in the relationship between mitochondrial signalling and systemic metabolic regulation.
FTPP Adipotide is the most directly targeted adipose tissue compound in this class. It is a pro-apoptotic peptide designed to selectively affect the vasculature serving fat tissues. Its mechanism of action has been explored in targeted vascular models as a potential means of influencing adipose tissue reduction. Tesofensine operates through a different mechanism entirely. As a serotonin-noradrenaline-dopamine reuptake inhibitor, it sits at the neurological end of the metabolic research spectrum. Its main area of interest lies in appetite regulation and central nervous system-mediated control of energy intake.
When tissue is damaged — whether through trauma, surgery or degenerative processes — the body activates a coordinated set of repair mechanisms involving cell migration, angiogenesis, inflammation modulation and remodelling of the extracellular matrix. The peptides in this category include some of the most recognised names in the Pharma Lab catalogue, each examined for its interaction with one or more aspects of the repair cascade.
BPC-157 is a synthetic pentadecapeptide derived from a protective protein naturally found in human gastric juice. It has generated an extensive research literature. Studies have explored its effects on wound healing, tendon and ligament repair, gastrointestinal protective properties and its potential to promote angiogenesis and reduce inflammation. One reason it is so widely studied is its versatility across different tissue types. From a mechanistic standpoint, BPC-157 is particularly interesting for its capacity to upregulate growth factor expression, attract blood vessel formation to injured areas and modulate nitric oxide signalling — all processes that facilitate accelerated tissue repair.
TB500 takes a completely different route to tissue repair. It is the synthetic version most closely related to Thymosin Beta-4, and its primary mechanism involves the regulation of actin — a protein essential for cell structure and movement. By influencing actin polymerisation, TB500 supports cell migration to injury sites, thereby contributing to wound healing and tissue regeneration. It has been investigated in areas ranging from muscle repair to cardiac tissue recovery, with a profile that combines anti-inflammatory activity with the promotion of cellular migration.
MGF Peptide and PEG-MGF represent the growth factor dimension of tissue repair. Mechano Growth Factor is a splice variant of IGF-1 that is expressed in response to mechanical stress placed on muscle tissue. It stimulates satellite cells — the dormant repair cells within muscle fibres — and initiates the process of muscle regeneration. PEG-MGF is the PEGylated form of this peptide, meaning a polyethylene glycol chain has been attached to prolong its time in circulation. This modification enables an extended duration of activity in research conditions, making PEG-MGF suitable for studies investigating processes that require sustained muscle repair and regenerative capacity.
PTD-DBM completes this category with a focus on bone rather than soft tissue. This peptide is studied for its involvement in bone morphogenetic pathways, specifically its ability to influence the differentiation of cells involved in bone formation and regeneration. PTD-DBM is a specialised tool for researchers working in skeletal tissue biology, with applications in fracture healing, bone regeneration and broader musculoskeletal repair.
Ageing is not a single process. It is an accumulation of multiple biological changes: telomere shortening, senescent cell accumulation, mitochondrial dysfunction, declining NAD+ levels, reduced stem cell activity and the gradual breakdown of tissue repair mechanisms. Pharma Lab provides seven compounds that each target different hallmarks of ageing, giving researchers the tools to study longevity from multiple directions.
Epithalon sits at the intersection of telomere biology and ageing research. This tetrapeptide is investigated for its telomerase activation properties — a feature that holds the potential to stimulate the rebuilding and extension of telomeres, the protective caps found at the ends of chromosomes that shorten with each cell division. Telomere shortening is one of the best-established markers of cellular ageing, and Epithalon's potential ability to intervene in that process makes it one of the most discussed longevity peptides available.
FOXO4-DRI approaches ageing from a wholly different angle. It is a senolytic peptide that targets the interaction between the FOXO4 protein and p53 in senescent cells. Senescent cells are those that have stopped dividing but persist in tissues, secreting harmful inflammatory molecules that damage neighbouring cells. FOXO4-DRI works by selectively disrupting the survival pathway that ordinarily prevents these cells from undergoing apoptosis, thereby facilitating their clearance.
GHK-Cu is a naturally occurring tripeptide bound to copper that bridges the themes of ageing and regenerative biology. Its effects on several biological processes have been documented in studies including collagen synthesis, skin remodelling, wound healing and antioxidant enzyme expression. The copper-binding properties of this peptide may help activate gene programmes involved in tissue repair and regeneration, linking it to both dermatological and systemic ageing research.
NAD+ occupies a central position in cell biology, and its decline with age is perhaps the single most reproducible observation in longevity research. NAD+ is an essential coenzyme in hundreds of metabolic reactions, including mitochondrial energy production, DNA repair and sirtuin activity — a family of proteins that modulate cellular stress response and lifespan. Pharma Lab provides NAD+ to researchers investigating the effects of supplementation on cellular NAD+ levels and their role in age-associated decline.
Humanin is a small twenty-one amino acid peptide with notable characteristics. Like MOTS-C, it is encoded by the mitochondrial genome, but Humanin's research profile is centred on cytoprotection — its protective effects on cells subjected to stress-induced cell death. Studies have focused on neuronal survival, oxidative stress resistance and cellular resilience, making it relevant to research examining mitochondrial-derived signals in the context of longevity and tissue preservation.
Pinealon and Cartalax both belong to the bioregulator peptide tradition, a school of investigation that examines how short peptide sequences interact with DNA and chromatin in various tissues to influence gene expression. Pinealon is a tripeptide studied for its effects on the functional activity of the central nervous system and pineal gland. Cartalax has specific application to cartilage and musculoskeletal tissues, and research examines its role in regulating gene expression patterns associated with joint health and structural tissue maintenance during ageing.
The immune system does not operate as a single entity. It is a layered hierarchy of innate defence and adaptive response, inflammatory mediators and regulatory mechanisms that must remain in dynamic balance across an entire organism. Pharma Lab provides seven peptides targeting different aspects of immune function, ranging from thymic health and T-cell biology to antimicrobial defence and mucosal inflammation.
Thymic peptides belong naturally in this category. Thymosin Alpha-1 is a well-characterised thymic peptide with documented effects on T-cell differentiation, enhanced dendritic cell function and altered cytokine production. It has been extensively investigated in the contexts of immune deficiency, chronic infection and the age-related loss of thymic function known as thymic involution. Thymalin operates along similar pathways but at a broader level, working to restore general thymic homeostasis and fundamental immune balance. Vilon is a dipeptide bioregulator that operates at the epigenetic level of thymic biology. Studies suggest it affects transcriptional programmes controlling the differentiation of immune cell populations including T-helper and cytotoxic T-cells, providing a unique experimental tool for gene expression studies examining how short peptide sequences regulate immune responsiveness at the genomic level.
LL-37 functions within a completely distinct arm of the immune system. It is the only human cathelicidin antimicrobial peptide, and its role in innate immunity has been assessed across a wide variety of settings. Although LL-37 can directly disrupt microbial membranes, its functions extend well beyond straightforward antimicrobial activity. It regulates inflammatory processes, influences wound healing and contributes to the recruitment of immune cells to sites of infection or injury. For scientists studying the role of innate immunity in tissue defence, LL-37 represents a versatile and powerful research tool.
KPV is a tri-peptide fragment of alpha-melanocyte-stimulating hormone, and its research profile centres on anti-inflammatory activity, particularly in mucosal tissues. It has been studied for its effects on intestinal inflammation, mucosal barrier integrity and the regulation of pro-inflammatory cytokines. Its specificity for mucosal surfaces makes it relevant to researchers examining gut immune function and inflammatory conditions of the bowel.
Bronchogen is the only peptide in this category that targets the respiratory system specifically. It is a tripeptide bioregulator studied for its influence on bronchial tissue health and respiratory function, with particular interest in how it affects gene expression in pulmonary epithelial cells. Vasoactive intestinal peptide, or VIP, completes this category with a broad-spectrum profile that includes immune modulation, neuroprotection and anti-inflammatory activity. VIP has been shown to modulate immune responses in models of autoimmune disease as well as neurodegenerative research settings, highlighting its ability to affect both the immune system and the nervous system simultaneously.
The brain is the most metabolically demanding organ in the body, and maintaining its function over a full lifetime represents one of the greatest challenges in modern neuroscience. Pharma Lab provides six peptides that act on different neurochemical pathways to influence cognitive function, neuroprotection, sleep regulation and neuroplasticity.
Selank and Semax are often considered together owing to their shared research heritage and overlapping cognitive effects, though their mechanisms of action are entirely different. Selank is a synthetic analogue of tuftsin, an immunomodulatory peptide. Its primary research focus centres on its interaction with GABA receptor systems. Selank has been associated with anxiolytic effects and has been correlated with gene regulation across several neurotransmission pathways including GABAergic signalling, excitatory-inhibitory balance and dopamine-related processes.
Semax, in contrast, is an analogue of adrenocorticotropic hormone. Its mechanism of action operates predominantly through modulation of brain-derived neurotrophic factor expression and cognitive function. BDNF is one of the most central molecules in neuroplasticity, and Semax's capacity to influence its expression has led to recognition of its potential both as a memory and learning enhancer and as a factor supporting neuronal survival in conditions where BDNF levels or signalling are disrupted.
P-21 Peptide focuses primarily on the regenerative and restorative dimension of cognitive research. Based on ciliary neurotrophic factor, P-21 is studied for its relevance to neuronal repair and synaptic regeneration, as well as the restoration of cognitive capacity following central nervous system injury. Unlike Selank and Semax, which modulate existing neuronal function, P-21 targets the actual structural repair of neural networks.
Sleep and wakefulness are two sides of the same neurological process, and Pharma Lab has peptides that address each. Delta Sleep-Inducing Peptide, or DSIP, has effects on sleep architecture and has been shown to modulate stress responses and regulate sleep-wake cycles. Orexin A occupies the opposite end of the spectrum, participating in the orexin peptide system that regulates waking, appetite and energy homeostasis. Researchers with an interest in sleep disorders, circadian biology or the neurochemistry of consciousness can use both peptides to explore these tightly coupled regulatory systems.
Adamax rounds out this category as a nootropic peptide investigated for its effects on cognitive function and neuroprotection. Research applications include the study of memory formation, attention and the maintenance of cognitive capacity under conditions of neurological stress.
The hypothalamic-pituitary-gonadal axis is one of the most complex hormonal systems in the body, and studying it requires peptide molecules that can act at distinct points along the signalling cascade. Pharma Lab supplies eight peptides that target this area from multiple directions within hormonal signalling.
At the apex of the reproductive axis sits gonadotropin-releasing hormone, and three peptides in this category interact directly with it. Gonadorelin is the synthetic GnRH agonist used to stimulate pituitary release of luteinising hormone and follicle-stimulating hormone in research settings. Kisspeptin operates one level upstream in the hypothalamus as a natural stimulator of GnRH neurons. The discovery of Kisspeptin's role in initiating puberty and in reproductive neuroendocrinology transformed the field, and it remains one of the most actively studied peptide hormones in reproductive science. Triptorelin is a GnRH agonist with the characteristic of producing long-term suppression of gonadotropin release after an initial stimulatory phase, giving it applicability in studies of hormonal downregulation.
Human Chorionic Gonadotropin and Human Menopausal Gonadotropin form the gonadotropin side of reproductive research. HCG mimics luteinising hormone and is examined for its effects on gonadal function, steroidogenesis and fertility pathways. HMG combines both FSH and LH activity, providing a unique experimental tool for researchers seeking to activate both branches of pituitary gonadotropin signalling simultaneously.
PT-141 stands apart from the rest of this category because it does not act through the hypothalamic-pituitary-gonadal axis at all. It is an agonist of the melanocortin receptor, particularly the MC3 and MC4 receptors in the brain, with research applications focused on sexual function and arousal mechanisms. This central mechanism of action distinguishes it from every other compound in the category.
Oxytocin connects reproductive physiology with social neuroscience. Often referred to as the bonding hormone, it is investigated for multiple functions related to uterine contraction, lactation, social bonding, trust and emotional regulation. Its implications extend well beyond reproduction into the broader study of how neuropeptides influence social behaviour, making it one of the most interdisciplinary compounds in the Pharma Lab catalogue.
Protirelin, or thyrotropin-releasing hormone, acts on the thyroid axis rather than the gonadal axis and is therefore classified as a hormonal research peptide. It is used in research to investigate neuroendocrine signalling and the interactions between different hormonal axes, stimulating the pituitary to release thyroid-stimulating hormone.
The regulation of skeletal muscle mass has interested researchers for many decades and is now understood to be controlled by a carefully balanced interaction between anabolic and catabolic signalling pathways. Among these, the myostatin pathway has attracted considerably increased attention because it functions as a natural brake on muscle growth. Pharma Lab offers four peptides that enable researchers to explore muscle biology from both sides of that equation.
Myostatin, formally known as GDF-8 or Growth Differentiation Factor 8, is the negative regulator. It instructs muscle cells to stop growing, and mutations that inactivate myostatin result in substantial muscle gains observed across multiple species. Pharma Lab provides GDF-8 Myostatin to researchers studying the protein directly — whether the aim is to understand its signalling pathways, characterise receptor interactions or develop strategies for biologically modulating myostatin activity.
ACE-031 and Follistatin 344 represent two different methods of blocking the growth-limiting signal that myostatin sends. ACE-031 is a soluble activin type IIB decoy receptor that traps myostatin and related ligands before they can interact with their target receptors on muscle cells. It functions as a molecular trap, effectively neutralising myostatin signalling. This mechanism is well characterised and has been researched for its potential to induce muscle hypertrophy. Follistatin 344 achieves a similar outcome but through a different mechanism. As an activin-binding protein, Follistatin antagonises the activity of myostatin and other members of the TGF-beta superfamily. Research into Follistatin 344 has examined its effects on muscle mass, strength and the balance between anabolic and catabolic processes in muscle tissue.
IGF-1 LR3 operates through a completely different pathway involving growth factors. It is a long-acting variant of Insulin-like Growth Factor 1 that has been modified to resist binding by IGF-binding proteins, significantly extending its biological half-life and increasing its potency at the receptor level. IGF-1 LR3 is one of the most extensively studied growth factors in muscle biology, with applications spanning cell proliferation, protein synthesis and anabolic signalling across multiple tissue types.
The skin is the largest organ in the body, and its biology extends far deeper than its surface appearance suggests. From the stimulation of melanin production and collagen architecture to antioxidant defence and neuromuscular signalling at the dermal level, the research in this category covers skin science across multiple dimensions.
Melanotan 1 and Melanotan 2 are both melanogenesis-promoting agents, but they act on different receptors with important additional research implications. Melanotan 1 is a linear analogue of alpha-melanocyte-stimulating hormone that selectively binds to the MC1 receptor, providing a focused tool for studying melanin production and UV protection mechanisms. Melanotan 2 is a cyclic peptide with activity across a wider range of melanocortin receptors. Its action on MC1, MC3, MC4 and MC5 receptors means that its effects extend beyond melanogenesis to include sexual function, appetite modulation and inflammation. This broader activity profile makes Melanotan 2 a more versatile but less selective research compound than Melanotan 1.
SNAP-8 and Matrixyl address the structural biology of skin from complementary angles. SNAP-8, or Acetyl Octapeptide-3, has been researched as a neuromuscular signalling modulator in skin. It interacts with the SNARE complex responsible for neurotransmitter release at the dermal level, and studies have explored its ability to affect the relaxation patterns of facial muscle contraction — directly influencing how skin moves. Matrixyl, a palmitoyl pentapeptide, addresses a different dimension of skin biology altogether. It is studied for its role in stimulating collagen synthesis and extracellular matrix repair, and has been investigated as a signalling peptide that prompts tissue to restore its natural production of structural proteins. Together, these two compounds represent both the mechanical and structural aspects of dermatological peptide research.
L-Glutathione is an antioxidant tripeptide composed of glutamic acid, cysteine and glycine. Its research relevance in dermatology comes from two functions: it is one of the most potent endogenous antioxidants protecting cells from oxidative stress, and it plays an important role in melanin regulation. Studies examining how glutathione levels influence the ratio of eumelanin to pheomelanin production highlight its unique position as a compound that bridges both antioxidant biology and skin pigmentation research.
Not every peptide fits neatly into a single established category, and some of the most compelling compounds in the Pharma Lab catalogue are those that open windows onto areas of biology that are still being fully characterised. This section brings together five products that serve completely different and highly specialised research niches.
ARA-290 is an engineered variant of erythropoietin that retains the beneficial cytoprotective and tissue-protective properties of the original molecule while removing its erythropoietic — or blood cell-producing — effects. It acts through the innate repair receptor, a heteromer of the erythropoietin receptor and common beta chain, and has been studied in models of neuropathy, tissue ischaemia and inflammatory damage. Because it can provide tissue protection without simultaneously stimulating red blood cell production, ARA-290 serves as a uniquely targeted research tool.
B7-33 targets the relaxin receptor RXFP1 and occupies a narrow but important niche in fibrotic and cardiovascular biology. As a pathway-selective relaxin receptor agonist, B7-33 may expand experimental approaches to exploring the role of relaxin signalling in tissue remodelling, collagen regulation and vascular function, while limiting engagement with related receptor systems.
PNC-27 occupies a unique position in cancer biology research. This peptide interacts with the p53-HDM2 binding site and has been studied for its selective capacity to disrupt the membranes of cells that overexpress HDM2. Its mechanism of action is distinctive because relatively few compounds in the oncological literature target the cell membrane rather than intracellular pathways.
Human C-peptide interacts with one of the most well-characterised hormonal systems in medicine — insulin signalling. C-peptide is released from proinsulin during insulin synthesis and was long believed to be biologically inert. That assumption has been challenged by more recent studies exploring the possibility that C-peptide itself has signalling roles relevant to diabetic complications, microvascular health and nerve function. Pharma Lab supplies research-grade C-peptide to investigators working in this area.
Pharma Lab offers Vitamin B12 in a nasal spray format, including the biologically active form methylcobalamin. Researchers are interested in the metabolic role of B12 as an essential nutrient for energy production and myelin formation, and nasal delivery supports investigation into alternative routes for bioactive compound delivery. Although not a peptide in the strict sense, its inclusion in the catalogue reflects growing interest within the research community in novel delivery formats for compounds with established biological activity.
This is a broad catalogue spanning sixty-five products across ten distinct research categories. What holds it together is a quality standard that applies uniformly, regardless of the type of peptide, its complexity or its intended application.
All peptides provided through Pharma Lab are produced with a minimum purity of ninety-nine per cent, with complex sequences reaching ninety-eight per cent or higher. These purities are verified through two complementary analytical methods. HPLC separates the constituents of each batch and provides the quantitative measurement required for accurate purity assessment. Mass spectrometry then verifies that the observed molecular weight of the peptide matches the theoretical weight of the intended sequence, confirming that the correct molecule has been synthesised. Together, these dual tests ensure not only that what you receive is of documented purity but also that it has been correctly synthesised.
A Certificate of Analysis is provided for each batch, containing the actual analytical results from both tests. These are not recycled templates. They are batch-specific documents that offer complete transparency regarding the quality of the product you are working with. Pharma Lab also extends a standing invitation for any researcher to submit products to a suitably qualified independent, third-party laboratory for verification. Independent testing is not merely tolerated — it is encouraged, because transparency at this level is the most meaningful trust signal a supplier can provide.
All peptides are sourced directly from manufacturing partners. Pharma Lab never purchases generic stock from third-party distributors. This direct relationship provides control over synthesis protocols, quality control procedures and raw material sourcing that could not be reliably achieved through downstream purchasing. Whether the product is BPC-157 from the tissue repair category or Epithalon from the longevity range, the same quality infrastructure underpins every item in the catalogue.
All products listed on this page are supplied by Pharma Lab for research and laboratory use only. They are not intended for human or animal consumption. They are not drugs, foods, cosmetics or medicinal preparations and must not be labelled or used as such.
All product descriptions, category information and educational content on this page are provided for informational and educational purposes only. Nothing presented here should be interpreted as medical advice, a treatment recommendation or a statement intended to prevent, diagnose or cure any disease or medical condition.
These products should only be used by appropriately qualified and properly trained research professionals in suitable laboratory settings. By interacting with Pharma Lab and its products, the researcher acknowledges and agrees to assume responsibility for the use of research-grade materials and agrees to comply with all relevant local, regional and national regulations.
Building a catalogue this extensive has never been about compiling the longest list of product names. It has been about ensuring that a researcher working in any major area of peptide science can find exactly what they need under one roof, with the same quality guarantee, the same testing rigour and the same transparency that characterises everything Pharma Lab does.
This catalogue captures the wide spectrum of modern peptide research, ranging from growth hormone secretagogues to senolytic peptides, from antimicrobial defence molecules to mitochondrial-derived metabolic regulators. All sixty-five compounds are here because scientists asked for them, because the science called for them and because Pharma Lab confirmed it could deliver them to the purity level this work demands.
The catalogue will expand over time as new peptides emerge from discovery programmes and as the demand for novel tools grows to address new research questions. But one thing will not change — the standard that every product must meet. Ninety-nine per cent purity. HPLC and mass spectrometry testing of every batch. Direct manufacturer relationships. Transparent documentation. And a team that understands both how the science works and how to deliver the materials it requires.
Your peptide is here, regardless of your research question or where your laboratory is located. And it is exactly what the label says it is.